José Luis
Lanciego Pérez
Investigador Senior
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (4)
2023
-
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
Parkinsonism and Related Disorders, Vol. 110
-
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Neurobiology of Disease, Vol. 188
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
2018
-
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081